Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.50
-0.34 (-2.46%)
Aug 31, 2026, 9:55 AM EDT - Market open

Bioventus Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
29.4651.2441.5836.9630.1943.93
Cash & Short-Term Investments
30.3951.2441.5836.9630.1943.93
Cash Growth
-7.65%23.22%12.49%22.45%-31.29%-49.41%
Receivables
138.41128.3127.39123.05136.56125.05
Inventory
79.8182.2492.4891.3384.7761.69
Prepaid Expenses
8.9211.0714.1616.6618.2827.16
Restricted Cash
-----5.28
Other Current Assets
----2.78-
Total Current Assets
257.53272.84275.61268272.58263.1
Property, Plant & Equipment
24.7527.0233.5249.9644.1540.17
Long-Term Investments
3.512.291.893.142.6229.29
Goodwill
7.467.467.467.467.46147.62
Other Intangible Assets
351.05368.42404.73482.35639.85695.19
Long-Term Deferred Tax Assets
29.055.524.75--0.48
Other Long-Term Assets
----405.9950
Total Assets
673.35683.56727.96810.911,3731,226

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
20.210.9323.6923.0436.716.92
Accrued Expenses
42.7951.6265.6155.4537.7766.26
Current Portion of Long-Term Debt
18.751527.3427.8533.0618.04
Current Portion of Leases
4.144.213.924.823.613.5
Current Income Taxes Payable
6.165.143.874.752.578.14
Other Current Liabilities
60.4173.4985.9859.59190.3168
Total Current Liabilities
152.45160.38210.4175.5304.02180.86
Long-Term Debt
229.7278.95308.29367385.01339.64
Long-Term Leases
11.1513.1916.5120.9614.4315.04
Long-Term Deferred Tax Liabilities
0.570.430.561.212.25133.52
Other Long-Term Liabilities
2.062.166.5925.13254.7223.01
Total Liabilities
395.93455.11542.35589.79960.43692.07

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.080.080.080.080.080.08
Additional Paid-In Capital
527.93520.85508.09494.25490.58465.27
Retained Earnings
-298.38-334.93-357.66-321.54-165.31-6.6
Comprehensive Income & Other
-1.33-1.9-2.570.79-0.110.18
Total Common Equity
228.31184.11147.94173.59325.24458.92
Minority Interest
49.1144.3437.6647.5386.9874.87
Shareholders' Equity
277.41228.45185.6221.12412.22533.79
Total Liabilities & Equity
673.35683.56727.96810.911,3731,226

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
263.75311.35356.06420.62436.1376.22
Net Cash (Debt)
-233.36-260.11-314.47-383.66-405.92-332.29
Net Cash Growth
------
Net Cash Per Share
-3.35-3.77-4.87-6.12-6.61-7.31
Filing Date Shares Outstanding
68.3167.3766.1663.3862.2760.6
Total Common Shares Outstanding
68.2167.165.7663.2762.0659.55
Working Capital
105.08112.4665.2192.5-31.4482.24
Book Value Per Share
3.352.742.252.745.247.71
Tangible Book Value
-130.2-191.78-264.25-316.22-322.08-383.89
Tangible Book Value Per Share
-1.91-2.86-4.02-5.00-5.19-6.45
Machinery
-44.7347.444.238.0729.1
Leasehold Improvements
-4.344.093.763.353.13
SEC Filings: 10-K · 10-Q